Paediatric medicines: Research and development

This section provides information on the European Medicines Agency's activities relating to paediatric medicines during the research and development stage. This includes guidance on paediatric investigation plans (PIPs).

In this section

• Funding for paediatric studies
• Needs for paediatric medicines
• Paediatric clinical trials
• Paediatric investigation plans
• Rewards and incentives for paediatric medicines
• Scientific guidelines paediatrics